Gaboxadol

DRUG10 trials

Sponsors

H. Lundbeck A/S, Healx AI, Craig Erickson

Conditions

Fragile X SyndromeInsomniaPrimary Disease or Condition Being Studied: Angelman Syndrome (AS)Primary Insomnia

Phase 2

Placebo-Controlled, Single-Dose Challenge Study of Gaboxadol in Adult Males With Fragile X Syndrome (FXS)

CompletedNCT06334419

Craig EricksonFragile X Syndrome

Start: 2024-01-29End: 2025-06-24Updated: 2025-12-23

Phase 3

Adult Primary Insomnia Polysomnographic Study (0928-004)(COMPLETED)

CompletedNCT00094627

H. Lundbeck A/SPrimary Insomnia

Start: 2004-11-30End: 2006-04-30Updated: 2015-01-14

Study of MK0928 in Healthy Adult Volunteers in a Model of Insomnia (0928-006)(COMPLETED)

CompletedNCT00102167

H. Lundbeck A/SInsomnia

Start: 2005-02-28End: 2005-12-31Updated: 2015-01-14

An Investigational Study of MK0928 in Adult Outpatients With Insomnia (0928-014)(COMPLETED)

CompletedNCT00103818

H. Lundbeck A/SInsomnia

Start: 2005-02-28End: 2006-10-31Updated: 2015-01-14

A Study of Gaboxadol in Primary Insomnia

CompletedNCT00209846

H. Lundbeck A/SPrimary Insomnia

Start: 2004-06-30End: 2006-11-30Target: 320Updated: 2007-03-30

A Prospective Open-Label Extension Study of Gaboxadol in Primary Insomnia

CompletedNCT00209950

H. Lundbeck A/SPrimary Insomnia

Start: 2004-07-31End: 2005-09-30Target: 200Updated: 2007-03-30

A Prospective Active-Reference Study of Gaboxadol in Primary Insomnia

CompletedNCT00209937

H. Lundbeck A/SPrimary Insomnia

Start: 2003-01-31End: 2004-06-30Target: 675Updated: 2007-03-30

A Study of Gaboxadol in Primary Insomnia

CompletedNCT00209924

H. Lundbeck A/SPrimary Insomnia

Start: 2004-04-30End: 2005-11-30Target: 505Updated: 2007-03-30

A Study of Gaboxadol in Primary Insomnia

CompletedNCT00209963

H. Lundbeck A/SPrimary Insomnia

Start: 2003-06-30End: 2005-03-31Target: 600Updated: 2007-03-30

A Study of OV101 in Individuals With Angelman Syndrome (AS)

CompletedNCT04106557

Healx AIPrimary Disease or Condition Being Studied: Angelman Syndrome (AS)

Start: 2019-09-09End: 2020-11-02Updated: 2024-01-08

Related Papers

Gaboxadol in angelman syndrome: A double-blind, parallel-group, randomized placebo-controlled phase 3 study.

2023-08-018 citations

How well can a large number of polysomnography sleep measures predict subjective sleep quality in insomnia patients?

2019-09-1110 citations

EEG power spectra response to a 4-h phase advance and gaboxadol treatment in 822 men and women.

2011-10-0115 citations

Effect of gaboxadol on patient-reported measures of sleep and waking function in patients with Primary Insomnia: results from two randomized, controlled, 3-month studies.

2010-02-0117 citations